Market News Latest

Creative Biolabs Announces a Wide Range of Services to Support Neuroscience Research

 Breaking News
  • No posts were found

Creative Biolabs Announces a Wide Range of Services to Support Neuroscience Research

November 21
14:48 2022
Since it began offering dependable neuroscience research services that support the discovery of potential therapeutic approaches for neurological diseases, Creative Biolabs has received high praise from clients both domestically and abroad and is constantly enhancing itself by keeping up with the most recent scientific trends.

New York, USA – November 21, 2022 – Currently, neurological disease treatment is one of the most arduous challenges for researchers to overcome in human disease, especially for patients suffering from heavy physical and emotional burdens. Meanwhile, the discovery of various potential therapeutic approaches for neurological disorders has implemented great hopes, thanks to advancements in medical technology. Scientists and technicians at Creative Biolabs can provide diverse neurological research services to push forward the development of novel therapeutic approaches for neurological disease treatment.

For example, a wide range of basic neuroscience assays provided at Creative Biolabs can be used to monitor the effects of a variety of factors, such as neurotoxicity, neuronal activity, and neural cell culture conditions. Neuroscience assays at Creative Biolabs include but are not limited to:

* Calcium assay service

* Neurotoxicity screening service

* Neuronal activity monitor service

* High-throughput phenotypic screen service

“Central nervous system (CNS) diseases have troubled researchers’ working progress for a long time, and the research for CNS drug discovery has never stopped,” said a scientist at Creative Biolabs.

Creative Biolabs has demonstrated outstanding capabilities by successfully completing hundreds of CNS drug discovery programs based on mature neuroscience assays and diverse research tools. The company is currently assisting its partners in discovering novel strategies for CNS disease treatments by providing one-stop CNS drug discovery services.

“Aside from drug discovery, CNS disease modeling is a very useful tool for researching these neurological diseases,” the scientist added.

Indeed, the advent of induced pluripotent stem cells (iPSCs) offers great opportunities for developing neuroscience cell models to investigate neurological diseases and related treatments, especially for CNS disease modeling. Creative Biolabs offers researchers a wide range of disease modeling services through its professional platforms, including custom CNS disease modeling services, custom neural differentiation services, and many more.

To learn more about the neuroscience research services and solutions provided at Creative Biolabs, please visit https://neurost.creative-biolabs.com.

About Creative Biolabs

Creative Biolabs is a biotech CRO company based in New York, United States, dedicated to providing neuroscience research services for decades. In confronting the challenges of novel drug discovery for neurological disorders, Creative Biolabs teamed up with outstanding scientists who have been devoted to developing services and products that support neuroscience studies for years and is honored to offer global customers access to a wide range of services based on their needs.

Media Contact
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email
Phone: 1-631-830-6441
Country: United States
Website: https://neurost.creative-biolabs.com